The past eight years has seen the Forbion team make more than 35 investments across Europe and the US, resulting in top-quartile returns. During this period we have also served on the Board of Directors of nearly all our portfolio Companies.
The team's complementary skill set provides insight into most areas of drug discovery and development, including anti-sense technology, biologicals, gene therapy, scaffold technology and medicinal chemistry. Technical knowledge of medical devices, manufacturing, clinical development, regulatory filings and protocol approvals is a key asset of our team. In terms of medical specialties, our team has clinical experience in gastroenterology, respiratory medicine, intensive care medicine, therapeutic immunomodulation, haemostasis & thrombosis, infectious diseases, arthritis & pain, female health and CNS diseases.